Example: Heart Attack
Clinical Trials on Glabellar Crease
Total 10000 results
-
NCT04963608Not yet recruitingHER2-positive Advanced Breast Cancer
-
NCT04742153RecruitingAdvanced or Metastatic Breast Cancer
-
NCT03048942RecruitingHER2 Negative Metastatic Breast Cancer
-
NCT04648904Active, not recruitingInvasive Breast Cancer | Post-mastectomy
-
NCT01101425Active, not recruiting
-
NCT04733118Active, not recruiting
-
NCT05064085CompletedHormone Receptor-positive Breast Cancer
-
NCT05230810Active, not recruitingHER2-positive Metastatic Breast Cancer
-
NCT01674140Active, not recruiting
-
NCT04872985Active, not recruitingBreast Cancer | Hormone-receptor Positive Breast Cancer
-
-
NCT04378751CompletedHigh Risk for Breast Cancer
-
NCT06533722CompletedHER2-negative Metastatic Breast Cancer
-
NCT02161900Active, not recruitingNon Metastatic Operable Breast Cancer
-
NCT02488564Completed
-
NCT06690320Enrolling by invitationBreast Cancer | Health Behavior | Breast Self-Examination
-
NCT02980341Completed
-
NCT03629717CompletedBreast Cancer Prevention | Mammographic Density
-
NCT01616758TerminatedMetastatic Breast Cancer
-
NCT04350021CompletedChemotherapy Effect | Breast Cancer Metastatic
-
-
NCT05519059CompletedAdvanced or Metastatic Breast Cancer
-
NCT05011279CompletedBreast Cancer | Breast Cancer Survivor | Fitness Trackers
-
NCT05103826TerminatedER+ / HER2- Advanced Breast Cancer
-
NCT03131440CompletedPhysical Activity | Breast Cancer Female
-
NCT05735392Completed
-
NCT05300412CompletedBreast Cancer Invasive
-
NCT03789877CompletedCancer Survivor | Invasive Breast Carcinoma
-
NCT04398108CompletedHER2 Positive Metastatic Breast Cancer
-
NCT03358589Active, not recruitingMetastatic Breast Cancer | Molecular Imaging
-
NCT01271920CompletedAdvanced HER2-positive Breast Cancer
-
-
NCT04290585CompletedHealthy Subject | Female Breast Carcinoma
-
NCT00140140TerminatedStage IV (Metastatic) Breast Cancer
-
NCT04163159UnknownMetastatic Breast Cancer | Mutation, Point
-
NCT01401062CompletedMetastatic Breast Cancer
-
NCT03799692Unknown
-
NCT02422199Unknown
-
NCT01090128Terminated
-
NCT01120561No longer available
-
NCT02102438WithdrawnBreast Cancer | HER-2 Positive Breast Cancer
-
NCT01151046Completed
-
NCT01948843CompletedHER2 Negative Metastatic Breast Cancer
-
NCT01388647TerminatedHER-2 Positive Breast Cancer
-
NCT00932373Completed
-
NCT01632956WithdrawnChinese Immigrants With Breast Cancer
-
NCT00875979Completed
-
NCT01208779CompletedHormon Receptor Positive Breast Cancer
-
NCT01272037Active, not recruitingBreast Ductal Carcinoma In Situ | Invasive Breast Carcinoma | Multicentric Breast Carcinoma | Multifocal Breast Carcinoma | Synchronous Bilateral Breast Carcinoma
-
NCT01071564TerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma
-
NCT07466303Not yet recruitingBreast Cancer | Serplulimab Combined With SHR-A1811 as Neoadjuvant Therapy for Triple-Negative Breast Cancer